Literature DB >> 31081422

High mortality from viral pneumonia in patients with cancer.

Youn-Jung Kim1, Eu Sun Lee2, Yoon-Seon Lee1.   

Abstract

Background: With the advancement of diagnostic methods, a viral infection is increasingly recognized in adult patients with pneumonia and the outcomes can be fatal especially in high-risk patients. We aimed to examine the clinical characteristics of adults with viral pneumonia and also to determine the associated factors with short-term mortality in those patients.
Methods: Adult patients who were diagnosed as viral pneumonia between January 2010 and December 2015 were consecutively included. Data were collected through reviews of electronic medical records. The primary outcome was 30-day mortality.
Results: A total of 1503 patients with viral pneumonia were included with a mean age of 66.0 years and male predominance in 60%. The most common viral pathogen was rhinovirus, followed by influenza virus and parainfluenza virus (PIV). Viral-bacterial co-infection and multiple viral infections were found in 24.5% and 5.2%, respectively. The 30-day mortality was 7.1% in total patients and it was not different according to viral pathogens. However, cancer patients had higher mortality than non-cancer patients for the PIV (12.3% vs. 3.8%, p < .05) and coronavirus (24.4% vs. 3.0%, p < .01) infections. On the multivariate analysis, old age (≥65) (OR 1.66, 95% CI: 1.06-2.60), viral-bacterial co-infection (OR 1.61, 95% CI: 1.05-2.48), malignancy (OR 2.26, 95% CI: 1.50-3.40), and shock at the initial presentation (OR 2.12, 95% CI: 1.03-4.37) were significantly associated with mortality. Conclusions: The mortality from viral pneumonia was high in adult patients. Old age, viral-bacterial co-infection, underlying malignancy, and initial shock were independent predictors of mortality.

Entities:  

Keywords:  Viral pneumonia; cancer; outcome

Mesh:

Year:  2019        PMID: 31081422     DOI: 10.1080/23744235.2019.1592217

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  17 in total

1.  Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia.

Authors:  Harry Gasper; Elizabeth Ahern; Natasha Roberts; Bryan Chan; Brett Hughes; Glen Kennedy; David Wyld; Melissa Eastgate; Zarnie Lwin
Journal:  BMJ Open       Date:  2021-05-06       Impact factor: 2.692

2.  Older Cancer Patients during the COVID-19 Epidemic: Practice Proposal of the International Geriatric Radiotherapy Group.

Authors:  Nam P Nguyen; Vincent Vinh-Hung; Brigitta Baumert; Alice Zamagni; Meritxell Arenas; Micaela Motta; Pedro Carlos Lara; Arthur Sun Myint; Marta Bonet; Tiberiu Popescu; Te Vuong; Gokula Kumar Appalanaido; Lurdes Trigo; Ulf Karlsson; Juliette Thariat
Journal:  Cancers (Basel)       Date:  2020-05-19       Impact factor: 6.639

3.  Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.

Authors:  Mengmeng Zhao; Menglong Wang; Jishou Zhang; Jian Gu; Pingan Zhang; Yao Xu; Jing Ye; Zhen Wang; Di Ye; Wei Pan; Bo Shen; Hua He; Mingxiao Liu; Menglin Liu; Zhen Luo; Dan Li; Jianfang Liu; Jun Wan
Journal:  Aging (Albany NY)       Date:  2020-06-04       Impact factor: 5.682

Review 4.  Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19.

Authors:  Peyvand Parhizkar Roudsari; Sepideh Alavi-Moghadam; Moloud Payab; Forough Azam Sayahpour; Hamid Reza Aghayan; Parisa Goodarzi; Fereshteh Mohamadi-Jahani; Bagher Larijani; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2020-06-25       Impact factor: 1.522

5.  COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).

Authors:  Frederic Di Fiore; Olivier Bouché; Come Lepage; David Sefrioui; Alice Gangloff; Lilian Schwarz; Jean Jacques Tuech; Thomas Aparicio; Thierry Lecomte; Camille Boulagnon-Rombi; Astrid Lièvre; Sylvain Manfredi; Jean Marc Phelip; Pierre Michel
Journal:  Dig Liver Dis       Date:  2020-05-14       Impact factor: 4.088

Review 6.  [The Effects and Management of Viral Pneumonia on Lung Cancer Patients].

Authors:  Yanhong Yao; Ming Lu; Yan'e Liu; Baoshan Cao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-03-26

7.  Re: "Strategy for the practice of digestive and oncological surgery during the COVID-19 epidemic".

Authors:  P Pessaux
Journal:  J Visc Surg       Date:  2020-04-10       Impact factor: 3.115

Review 8.  COVID-19 in the Cancer Patient.

Authors:  Cindy B Yeoh; Kathleen J Lee; Elizabeth F Rieth; Renee Mapes; Anna V Tchoudovskaia; Gregory W Fischer; Luis E Tollinche
Journal:  Anesth Analg       Date:  2020-07       Impact factor: 5.108

9.  When cancer encounters COVID-19 in China: what have we suffered, experienced and learned.

Authors:  Haiyang Chen; Xuan Wu; Wei Wang; Qiming Wang
Journal:  Jpn J Clin Oncol       Date:  2020-06-10       Impact factor: 3.019

10.  [Re: "Strategy for the practice of digestive and oncological surgery during the COVID-19 epidemic"].

Authors:  P Pessaux
Journal:  J Chir Visc       Date:  2020-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.